Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

Author:

Gramenzi Annagiulia1,Golfieri Rita2,Mosconi Cristina2,Cappelli Alberta2,Granito Alessandro1,Cucchetti Alessandro1,Marinelli Sara1,Pettinato Cinzia3,Erroi Virginia1,Fiumana Silvia1,Bolondi Luigi1,Bernardi Mauro1,Trevisani Franco1,

Affiliation:

1. Department of Medical and Surgical Sciences; Alma Mater Studiorum - University of Bologna; Bologna Italy

2. Radiology Unit; S. Orsola-Malpighi Hospital; Bologna Italy

3. Medical Physics Unit; S. Orsola-Malpighi Hospital; Bologna Italy

Publisher

Wiley

Subject

Hepatology

Reference41 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection;Alazawi;Aliment Pharmacol Ther,2010

3. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

4. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer;J Hepatol,2012

5. Novel advancements in the management of hepatocellular carcinoma in 2008;Llovet;J Hepatol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3